The Study
Apolipoprotein CIII Reduction Protects White Adipose Tissues against Obesity-Induced Inflammation and Insulin Resistance in Mice
This study looked at mice that ate lots of fatty food and gave them a special medicine to lower one protein. They saw that the mice got healthier in some ways, but this doesn't mean the same thing will happen in people. It's like noticing that your pet dog feels better after eating carrots — it doesn't mean carrots will cure your friend's cold.
Analysis score
Maximum 90 for a randomized controlled trial.
Where the score came from
When mice eat too much fat, they get fat and sick—but shrinking a protein called apoCIII makes their fat cells smaller, less inflamed, and better at burning energy.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 516 / 100
Quality score
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes—this suggests that targeting apoCIII could help reverse obesity-related metabolic damage in humans, even after weight gain has already occurred.
- 2Mice treated with the treatment had smaller fat cells, 30–50% lower inflammatory proteins, 2–3x higher fat-burning genes, and normal blood sugar and insulin levels—even while eating the same fatty diet.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
International Journal of Molecular Sciences
Year
2021
Authors
Patricia Recio-López, Ismael Valladolid-Acebes, P. Berggren, L. Juntti-Berggren
Related Content
Claims (6)
Inflammatory molecules released by visceral fat cause insulin resistance, leading to increased fat storage by reducing fat breakdown and increasing new fat production.
In mice fed a high-fat diet, lowering apolipoprotein CIII reduces high blood sugar, high insulin, and high glucagon, and restores normal levels of adiponectin and leptin, without changes in eating or movement.
In mice fed a high-fat diet, lowering apolipoprotein CIII increases the activity of genes involved in heat production and fat tissue transformation in white adipose tissue.
In mice on a high-fat diet, lowering apolipoprotein CIII using antisense oligonucleotides is linked to smaller fat cells, lower levels of inflammatory molecules, and higher levels of genes involved in heat production in fat tissue.
In mice fed a high-fat diet, lowering apolipoprotein CIII allows insulin to suppress fat breakdown in fat cells from both under-the-skin and abdominal fat deposits.
In mice with diet-induced obesity, lowering apolipoprotein CIII using antisense oligonucleotides stops and reverses dysfunction in fat tissue, even when treatment starts after obesity is already present.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.